المؤلفون: Cesano, A, Cannarile, MA, Gnjatic, S, Gomes, B, Guinney, J, Karanikas, V, Karkada, M, Kirkwood, JM, Kotlan, B, Masucci, GV, Meeusen, E, Monette, A, Naing, A, Thorsson, V, Tschernia, N, Wang, E, Wells, DK, Wyant, TL, Rutella, S

المصدر: Journal for immunotherapy of cancer. 8(2)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:145426623

المؤلفون: Rutella, S, Cannarile, MA, Gnjatic, S, Gomes, B, Guinney, J, Karanikas, V, Karkada, M, Kirkwood, JM, Kotlan, B, Masucci, G, Meeusen, E, Monette, A, Naing, A, Thorsson, V, Tschernia, N, Wang, E, Wells, DK, Wyant, TL, Cesano, A

المصدر: Journal for immunotherapy of cancer. 8(2)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:145180656

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Heczey A; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu.; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu., Xu X; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Courtney AN; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Tian G; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Barragan GA; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Guo L; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Amador CM; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Ghatwai N; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Rathi P; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Wood MS; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Li Y; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Zhang C; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Demberg T; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Di Pierro EJ; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Sher AC; Department of Radiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Zhang H; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Mehta B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Thakkar SG; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Grilley B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Wang T; Biostatistics and Data Management Resource, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Weiss BD; Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, USA., Montalbano A; Immunai, Inc., New York, NY, USA., Subramaniam M; Immunai, Inc., New York, NY, USA., Xu C; Immunai, Inc., New York, NY, USA., Sachar C; Immunai, Inc., New York, NY, USA., Wells DK; Immunai, Inc., New York, NY, USA., Dotti G; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Metelitsa LS; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA. lsmeteli@txch.org.; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA. lsmeteli@txch.org.

المصدر: Nature medicine [Nat Med] 2024 Apr; Vol. 30 (4), pp. 1210.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Moran TE; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A., Ramamurti P; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A., Wells DK; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A., Thompson X; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A., Hart JM; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A., Diduch DR; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A., Brockmeier SF; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A., Miller MD; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A., Gwathmey WF; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A., Werner BC; Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A.

المصدر: Arthroscopy, sports medicine, and rehabilitation [Arthrosc Sports Med Rehabil] 2023 Sep 21; Vol. 5 (5), pp. 100798. Date of Electronic Publication: 2023 Sep 21 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101765256 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-061X (Electronic) Linking ISSN: 2666061X NLM ISO Abbreviation: Arthrosc Sports Med Rehabil Subsets: PubMed not MEDLINE

المؤلفون: Heczey A; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu.; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu., Xu X; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Courtney AN; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Tian G; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Barragan GA; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Guo L; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Amador CM; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Ghatwai N; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Rathi P; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Wood MS; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Li Y; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Zhang C; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Demberg T; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Di Pierro EJ; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Sher AC; Department of Radiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Zhang H; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Mehta B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Thakkar SG; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Grilley B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Wang T; Biostatistics and Data Management Resource, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Weiss BD; Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, USA., Montalbano A; Immunai, Inc., New York, NY, USA., Subramaniam M; Immunai, Inc., New York, NY, USA., Xu C; Immunai, Inc., New York, NY, USA., Sachar C; Immunai, Inc., New York, NY, USA., Wells DK; Immunai, Inc., New York, NY, USA., Dotti G; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Metelitsa LS; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA. lsmeteli@txch.org.; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA. lsmeteli@txch.org.

المصدر: Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1379-1388. Date of Electronic Publication: 2023 May 15.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Natural Killer T-Cells* , Receptors, Chimeric Antigen*/genetics , Neuroblastoma*/therapy, Child ; Animals ; Mice ; Humans ; Cytotoxicity, Immunologic ; Immunotherapy, Adoptive/methods

المؤلفون: Campbell KM; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: katiecampbell@mednet.ucla.edu., Amouzgar M; Department of Pathology, Stanford University, Stanford, CA 94305, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA., Pfeiffer SM; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA., Howes TR; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA., Medina E; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Travers M; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA., Steiner G; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA., Weber JS; Perlmutter Cancer Center, NYU School of Medicine, New York, NY 10016, USA., Wolchok JD; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA., Larkin J; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Boffo S; Bristol Myers Squibb Corp., Princeton, NJ 08540, USA., Salvador L; Bristol Myers Squibb Corp., Princeton, NJ 08540, USA., Tenney D; Bristol Myers Squibb Corp., Princeton, NJ 08540, USA., Tang T; Bristol Myers Squibb Corp., Princeton, NJ 08540, USA., Thompson MA; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA., Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA., Ribas A; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90024, USA. Electronic address: aribas@mednet.ucla.edu.

المصدر: Cancer cell [Cancer Cell] 2023 Apr 10; Vol. 41 (4), pp. 791-806.e4.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/genetics , Melanoma*/metabolism , Skin Neoplasms*/drug therapy , Skin Neoplasms*/genetics, Humans ; CTLA-4 Antigen/genetics ; Biomarkers, Tumor ; Immunotherapy ; Tumor Microenvironment

المؤلفون: Pai JA; Department of Pathology, Stanford University, Stanford, CA, USA; Immunology Program, Stanford University, Stanford, CA, USA., Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sauter JL; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mattar M; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Woo HJ; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shah N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nguyen EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Cancer Biology Program, Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Uddin FZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Quintanal-Villalonga A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chan JM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Manoj P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Allaj V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Baine MK; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bhanot UK; Precision Pathology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jain M; Precision Pathology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Linkov I; Precision Pathology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Meng F; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Brown D; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chaft JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA., Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gigoux M; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Won HH; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sen T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Santa Ana Bio, Alameda, CA, USA., Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wolchok JD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Loomis B; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Merghoub T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chow A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: chowa1@mskcc.org., Satpathy AT; Department of Pathology, Stanford University, Stanford, CA, USA; Immunology Program, Stanford University, Stanford, CA, USA; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Parker Institute for Cancer Immunotherapy, Stanford University, Stanford, CA, USA. Electronic address: satpathy@stanford.edu.

المصدر: Cancer cell [Cancer Cell] 2023 Apr 10; Vol. 41 (4), pp. 776-790.e7. Date of Electronic Publication: 2023 Mar 30.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy, Humans ; CD8-Positive T-Lymphocytes ; Immune Checkpoint Inhibitors/therapeutic use ; Receptors, Antigen, T-Cell ; Clone Cells ; Tumor Microenvironment

المؤلفون: Karasarides M; Worldwide Medical Oncology, Bristol Myers Squibb, Princeton, New Jersey., Cogdill AP; Immunai, New York, New York.; Department of Immunology, The University of Texas MD Anderson, Houston, Texas., Robbins PB; Instil Bio, Dallas, Texas., Bowden M; Translational Medicine, Bristol Myers Squibb, Cambridge, Massachusetts., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson, Houston, Texas., Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, California., Cesano A; ESSA Pharma Inc., South San Francisco, California., Hammer C; Department of Cancer Immunology, Genentech, South San Francisco, California.; Department of Human Genetics, Genentech, South San Francisco, California., Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Horak CE; Global Drug Development, Bristol Myers Squibb, Lawrenceville, New Jersey., McGee HM; Department of Radiation Oncology, City of Hope National Medical Center and Department of Immuno-Oncology, Beckmann Research Institute, City of Hope, Duarte, California., Monette A; Lady Davis Institute for Medical Research, Montréal, Québec, Canada., Rudqvist NP; University of Texas MD Anderson Cancer Center, Houston, Texas., Spencer CN; Department of Informatics, Parker Institute for Cancer Immunotherapy, San Francisco, California.; University of California San Francisco, San Francisco, California., Sweis RF; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.; Committee on Immunology, University of Chicago, Chicago, Illinois.; Comprehensive Cancer Center, University of Chicago, Chicago, Illinois., Vincent BG; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Wennerberg E; The Institute of Cancer Research, London, UK., Yuan J; Translational Oncology, Early Oncology Development Department, Merck Research Laboratories, Rahway, New Jersey., Zappasodi R; Weill Cornell Medicine, New York, New York.; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York., Lucey VMH; Worldwide Medical Oncology, Bristol Myers Squibb, Princeton, New Jersey., Wells DK; Immunai, New York, New York.; Parker Institute for Cancer Immunotherapy, San Francisco, California., LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, California.

المصدر: Cancer immunology research [Cancer Immunol Res] 2022 Apr 01; Vol. 10 (4), pp. 372-383.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological*/adverse effects , Neoplasms*, Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use

المؤلفون: Shakiba M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY., Zumbo P; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY., Espinosa-Carrasco G; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Menocal L; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Dündar F; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY.; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY., Carson SE; Department of Biochemistry, Cell and Molecular Biology, Weill Cornell Medicine, New York, NY., Bruno EM; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Sanchez-Rivera FJ; Cancer Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Lowe SW; Cancer Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Camara S; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Koche RP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY., Reuter VP; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY., Socci ND; Bioinformatics Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY., Whitlock B; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Tamzalit F; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY., Huse M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY., Hellmann MD; Parker Institute for Cancer Immunotherapy, San Francisco, CA.; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, Cornell University, New York, NY., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, CA., Defranoux NA; Parker Institute for Cancer Immunotherapy, San Francisco, CA., Betel D; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY., Philip M; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN., Schietinger A; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY.

المصدر: The Journal of experimental medicine [J Exp Med] 2022 Feb 07; Vol. 219 (2). Date of Electronic Publication: 2021 Dec 22.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE

مواضيع طبية MeSH: Signal Transduction* , Tumor Escape*, Neoplasms/*etiology , Neoplasms/*metabolism , Receptors, Antigen, T-Cell/*metabolism , T-Lymphocyte Subsets/*immunology , T-Lymphocyte Subsets/*metabolism, Animals ; Antigens, Neoplasm/immunology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Cell Line, Tumor ; Cytokines/metabolism ; Disease Models, Animal ; Epigenesis, Genetic ; Gene Expression Regulation, Neoplastic ; Humans ; Immunotherapy, Adoptive/methods ; Lymphocyte Activation/immunology ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Mice ; Neoplasms/pathology ; Neoplasms/therapy ; T-Cell Antigen Receptor Specificity